Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Details Narrative)

v3.22.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member]
$ in Millions
Jul. 12, 2017
USD ($)
Number
Jun. 12, 2017
USD ($)
API Supply Agreement [Member]    
Proceeds from supply agreement   $ 31.8
API Supply Agreement [Member] | PGLG [Member]    
Percentage of right to supply   25.00%
Agreement term   15 years
Revised API Agreement [Member]    
Agreement term 5 years  
Number of renewals | Number 10  
Cumulative purchase amount $ 47.0  
Annual purchase target amount 5.0  
Target profit $ 2.5